XML 18 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
REVENUE
6 Months Ended
Jun. 30, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Abstract]  
REVENUE
NOTE 3:-   REVENUE

The Company adopted ASC 606 effective January 1, 2018 using the modified retrospective method, applied to those contracts which were not substantially completed as of January 1, 2018. Such method provides that the cumulative effect from prior periods upon applying the new guidance be recognized in the consolidated balance sheets as of January 1, 2018, including an adjustment to accumulated deficit. A summary of such cumulative effect adjustment is as follows:

   
Increase (decrease)
 
Trade receivables
 
$
2,329
 
Deferred commission costs
   
4,526
 
Deferred taxes, net
   
(765
)
Deferred revenue
   
(539
)
Accumulated deficit
   
(6,629
)
 
Changes in accounting policies as a result of adopting ASC 606

The impact of the Company's adoption of ASC 606 primarily relates to the timing of revenue recognition from its term-based license agreements. Prior to the adoption of ASC 606, the Company recognized revenue from these agreements ratably over the license term. Under ASC 606, revenue allocable to the license portion of the arrangement is recognized upon delivery of the license. In addition, under ASC 606 the Company capitalizes certain incremental costs of obtaining a contract, while prior to the adoption of ASC 606, the Company expensed all contract costs as incurred.

Financial statements impact of adopting ASC 606

The following table discloses the impact of the adoption of ASC 606 on the Company’s consolidated statements of income and balance sheets:

   
Six months ended June 30, 2018
 
   
Unaudited
 
   
As reported
   
Under previous standard
   
Effect of change higher (lower)
 
Revenues:
                 
Software licenses
 
$
21,623
   
$
15,405
   
$
6,218
 
Maintenance and services 
   
16,424
     
15,828
     
596
 
Total revenues
   
38,047
     
31,233
     
6,814
 
                         
Operating expenses:
                       
Cost of sales
   
5,406
     
5,467
     
(61
)
Research and development
   
7,931
     
7,931
     
-
 
Selling and marketing
   
20,075
     
21,268
     
(1,193
)
General and administrative
   
2,964
     
2,964
     
-
 
Total operating expenses
   
36,376
     
37,630
     
(1,254
)
                         
Operating income (loss)`
   
1,671
     
(6,397
)
   
8,068
 
                         
Financial income (expenses), net
   
88
     
88
     
-
 
                         
Income (loss) before income taxes
   
1,759
     
(6,309
)
   
8,068
 
                         
Taxes on income
   
1,298
     
1,098
     
200
 
                         
Net income (loss)
 
$
461
   
$
(7,407
)
 
$
7,868
 
Basic and diluted net income (loss) per share
 
$
0.02
   
$
(0.35
)
 
$
(0.37
)
 
   
June 30, 2018
 
   
Unaudited
 
   
As reported
   
Under previous standard
   
Effect of change higher (lower)
 
Assets:
                 
Trade receivables, net
 
$
13,119
   
$
9,422
   
$
3,697
 
Deferred commission cost
   
5,741
     
-
     
5,741
 
Other assets
   
250
     
175
     
75
 
Deferred taxes, net
   
5
     
969
     
(964
)
Liabilities:
                       
Deferred revenue
   
16,631
     
22,548
     
(5,917
)
Shareholders’ Equity:
                       
Accumulated deficit
   
117,541
     
132, 007
     
(14,466
)